Search

Search Results
Results 81931 - 81940 of 83251 for cancer
  • Nexium Intravenous
    Drug - 6 Jun 2024
    Consumer Medicine Information (CMI) about Nexium Intravenous intended for persons living in Australia.
  • Nexium
    Drug - 6 Jun 2024
    Consumer Medicine Information (CMI) about Nexium intended for persons living in Australia.
  • Hyperthyroidism Diagnosis
    Health - 23 May 2024
    Hyperthyroidism is a health condition which results from the overactivity of the thyroid gland. It can be diagnosed by the presenting history and a physical examination, in addition to several tests...
  • Solu-Medrol
    Drug - 22 May 2024
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • Uremide 20
    Drug - 21 May 2024
    Consumer Medicine Information (CMI) about Uremide 20 (furosemide) intended for persons living in Australia.
  • Regulatory Challenges In Drug Approval: Balancing Innovation And Patient Safety
    Life Sciences - 8 May 2024
    The complex landscape of drug approval presents significant regulatory challenges.
  • Ngenla
    Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Ngenla intended for persons living in Australia.
  • Coveram
    Drug - 2 May 2024
    Consumer Medicine Information (CMI) about Coveram intended for persons living in Australia.
  • Iclusig
    Drug - 23 Apr 2024
    Consumer Medicine Information (CMI) about Iclusig intended for persons living in Australia.
  • Dexamethasone Viatris
    Drug - 19 Apr 2024
    Consumer Medicine Information (CMI) about Dexamethasone Viatris intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback